The use of autoinjectors to ensure controlled and efficient contrast delivery for imaging studies is fueling market growth in Western Europe.
A new study from market research firm Frost & Sullivan concluded the market achieved revenues of 35.6 million euros in 2013 and could reach 43.7 million euros in 2018. The report covers CT, MRI, and angiography autoinjectors.
To take advantage of the growth, autoinjector and imaging modality vendors are promoting bundles sales of the injector and imaging technologies.
However, budget constraints and further reimbursement reductions could slow growth in the market in the next few years, the report added.
